A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

Clinical trial NCT01578499 · COMPLETED

Trial details

NCT number: NCT01578499
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Cutaneous Anaplastic Large Cell Lymphoma Mycosis Fungoides Cutaneous T-Cell Lymphoma

Start date: 2012-06-11
Primary completion: 2016-05-31
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.